BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 9774183)

  • 1. Effect of ethanol on myocardial infarct size in a canine model of coronary artery occlusion-reperfusion.
    Itoya M; Morrison JD; Downey HF
    Mol Cell Biochem; 1998 Sep; 186(1-2):35-41. PubMed ID: 9774183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion.
    Zmudka K; Dubiel J; Vanhaecke J; Flameng W; De Geest H
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):479-87. PubMed ID: 7947365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
    Motoe M; Yoshida S
    Jpn Circ J; 1991 May; 55(5):490-9. PubMed ID: 2062000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary SIN-1C during reperfusion reduces infarct size in dog.
    Schlack W; Uebing A; Schäfer M; Bier F; Grunert S; Ebel D; Piper HM; Thämer V
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):424-31. PubMed ID: 7769808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion.
    Chareonthaitawee P; O'Connor MK; Gibbons RJ; Ritman EL; Christian TF
    Eur J Nucl Med; 2000 May; 27(5):508-16. PubMed ID: 10853805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size.
    Lee R; Nitta T; Schmid RA; Schuessler RB; Harris KM; Gay WA
    Ann Thorac Surg; 1998 May; 65(5):1353-9. PubMed ID: 9594866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: salvage or delay of myocyte necrosis?
    Przyklenk K; Kloner RA
    Basic Res Cardiol; 1987; 82(2):146-58. PubMed ID: 3606542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
    Preckel B; Schlack W; Gonzàlez M; Obal D; Barthel H; Thämer V
    Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent hypoxic training protects canine myocardium from infarction.
    Zong P; Setty S; Sun W; Martinez R; Tune JD; Ehrenburg IV; Tkatchouk EN; Mallet RT; Downey HF
    Exp Biol Med (Maywood); 2004 Sep; 229(8):806-12. PubMed ID: 15337835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reperfusion injury in dog hearts with permanent occlusion of a coronary artery, probably due to reperfusion via collateral vessels.
    Fujiwara Y; Fujiwara H; Matsuda M; Onodera T; Ishida M; Kawamura A; Okamoto Y; Ban T; Kawai C
    Int J Cardiol; 1991 Mar; 30(3):275-84. PubMed ID: 2055668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained myocardial protection by clentiazem (TA-3090) after a 90-minute coronary occlusion and 72 hours of reperfusion in dogs with collateral flow.
    Rousseau G; Provost P; Latour JG
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):264-72. PubMed ID: 7692168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
    Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acidotic blood reperfusion on reperfusion injury after coronary artery occlusion in the dog heart.
    Preckel B; Schlack W; Obal D; Barthel H; Ebel D; Grunert S; Thämer V
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):179-86. PubMed ID: 9475258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model.
    Smalling RW; Feld S; Ramanna N; Amirian J; Felli P; Vaughn WK; Swenson C; Janoff A
    Circulation; 1995 Aug; 92(4):935-43. PubMed ID: 7641377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Unloading Increases the Coronary Collateral Flow Index Before Reperfusion and Reduces Infarct Size in a Swine Model of Acute Myocardial Infarction.
    Briceno N; Annamalai SK; Reyelt L; Crowley P; Qiao X; Swain L; Pedicini R; Foroutanjazi S; Jorde L; Yesodharan G; Perera D; Kapur NK
    J Am Heart Assoc; 2019 Nov; 8(22):e013586. PubMed ID: 31698989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collateral perfusion through overlapping vessels reduces canine right ventricular ischemic injury from positive end-expiratory pressure.
    Johnston WE; Vinten-Johansen J; Shugart HE; Spray BJ; Santamore WP
    Crit Care Med; 1993 May; 21(5):721-32. PubMed ID: 8482094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model.
    Horrigan MC; Malycky JL; Ellis SG; Topol EJ; Nicolini FA
    Int J Cardiol; 1999 Apr; 68 Suppl 1():S85-91. PubMed ID: 10328616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II.
    Segawa D; Sjöquist PO; Wang QD; Gonon A; Rydén L
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):339-45. PubMed ID: 12198319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
    Fiedler VB; Perzborn E; Seuter F
    Pharmacotherapy; 1991; 11(1):77-84. PubMed ID: 2020615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.